Development of CDP-ribitol supplementation therapy based on the pathogenesis of glycosylation-deficient muscular dystrophy

Motoi Kanagawa

5:11 PM - 5:30 PM

[3PW-05-5] Development of CDP-ribitol supplementation therapy based on the pathogenesis of glycosylation-deficient muscular dystrophy

^○Motoi Kanagawa (Cell Biol. and Mol. Med., Grad. Sch. of Med., Ehime Univ.)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3PW-05-5] Development of CDP-ribitol supplementation therapy based on the pathogenesis of glycosylation-deficient muscular dystrophy

Password